These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 294806)

  • 21. Labeling of the glucocorticoid receptor and Na,K-ATPase in a rat otitis media model.
    Hultcrantz M; Erichsen S; Rylander R; Stierna P; Bagger-Sjöbäck D
    Am J Otol; 2000 Jan; 21(1):36-41. PubMed ID: 10651433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations.
    Ohyama M; Furuta S; Ueno K; Katsuda K; Nobori T; Kiyota R; Miyazaki Y
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):337-40. PubMed ID: 10190808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HSP70 expression of middle ear mucosa in acute suppurative otitis media].
    Bi AF; Zou J; Zhou YQ; Shang YD; Zhao QS
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 14(4):173-4. PubMed ID: 12541495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subepithelial space in otitis media.
    Paparella MM; Sipilä P; Juhn SK; Jung TT
    Laryngoscope; 1985 Apr; 95(4):414-20. PubMed ID: 2984491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome.
    Lasisi AO; Olayemi O; Arinola OG; Omilabu SA
    J Laryngol Otol; 2009 Oct; 123(10):1103-7. PubMed ID: 19640314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue penetration of erythromycin in Waldeyer's ring and bacteriology of secretory otitis media.
    Sundberg L; Edén T; Ernstson S; Cederberg A
    Acta Otolaryngol Suppl; 1981; 384():1-27. PubMed ID: 6285661
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyaluronan in experimental serous and purulent otitis media.
    Laurent C; Hellström S; Tengblad A; Lilja K
    Ann Otol Rhinol Laryngol; 1989 Sep; 98(9):736-40. PubMed ID: 2782807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serous otitis media and immunological reactions in the middle ear mucosa.
    van der Baan S; Seldenrijk CA; Henzen-Logmans SC; Drexhage HA
    Acta Otolaryngol; 1988; 106(5-6):428-34. PubMed ID: 3061276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of substance P upon middle ear effusion of secretory otitis media and the mode of action].
    Huang W; Jiang H; Qiu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Jun; 11(6):249-51. PubMed ID: 9812802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins in middle ear effusions.
    Bernstein JM; Okazaki T; Reisman RE
    Arch Otolaryngol; 1976 May; 102(5):257-8. PubMed ID: 1267715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythromycin in the middle ear: further information.
    Meland M
    Pediatrics; 1972 May; 49(5):784. PubMed ID: 4537602
    [No Abstract]   [Full Text] [Related]  

  • 32. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
    Esu Y; Masuda M; Yoshida N
    Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on middle ear effusions.
    Juhn SK
    Laryngoscope; 1982 Mar; 92(3):287-91. PubMed ID: 7200175
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoelectrophoretic study of proteins in middle ear effusion. A study of secretory otitis media in children.
    Pahor AL; Sözen N; Beetham R; Raine DN
    J Laryngol Otol; 1976 Nov; 90(11):1033-40. PubMed ID: 1003029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural morphology of mucoid effusion in secretory otitis media.
    Sipilä P; Sutinen S; Sutinen SH; Karma P
    Acta Otolaryngol; 1980; 90(5-6):342-52. PubMed ID: 7211328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compositional difference in middle ear effusion: mucous versus serous.
    Chung MH; Choi JY; Lee WS; Kim HN; Yoon JH
    Laryngoscope; 2002 Jan; 112(1):152-5. PubMed ID: 11802055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysozyme activity and immunoglobulins in middle ear effusion fluid in acute purulent otitis media and in otitis media with effusion.
    Virtanen S; Lahikainen EA
    Scand J Infect Dis; 1979; 11(1):63-7. PubMed ID: 419370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of collagenous protein levels in inflamed middle ear mucosa].
    Durko T; Gryczyński M; Dabrowski R
    Otolaryngol Pol; 1991; 45(3):208-12. PubMed ID: 1896187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonic acid metabolites in experimental otitis media and effects of anti-inflammatory drugs.
    Goldie P; Jung TT; Hellström S
    Ann Otol Rhinol Laryngol; 1993 Dec; 102(12):954-60. PubMed ID: 8285517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine and secretory otitis media.
    Collins MP; Bakhshi K; Wareham CA; Church MK
    Clin Sci (Lond); 1984 Nov; 67(5):557-60. PubMed ID: 6206979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.